School of Medicine
Showing 1,901-1,920 of 13,048 Results
-
Grace A Cheney
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioGrace Cheney, M.D. specializes in the assessment and treatment of ADHD across the lifespan. She serves as Director of the Adult ADHD Assessment Clinic at Stanford, which provides structured, developmentally informed evaluations for adults with attention and executive function challenges. Rooted in a neurodiversity-affirming framework, the clinic focuses on diagnostic clarity to support tailored, evidence-based care. As part of this model, the clinic incorporates the California ADHD Symptom Tracking (CAST) initiative, a semi-structured symptom-tracking method that fosters patient insight, supports individualized treatment planning, and promotes adherence.
With subspecialty training in both child and adolescent psychiatry and forensic psychiatry, Dr. Cheney’s diagnostic lens emphasizes precision and developmental context. She has particular expertise in the assessment of ADHD in women, transitional-age youth, and high-functioning professionals. Her treatment approach is comprehensive, and emphasizes establishing foundational non-pharmacological strategies in addition to pharmacological interventions.
Dr. Cheney lectures in the Forensic Psychiatry Fellowship on civil and child forensic topics, and she also supervises psychiatry residents and fellows in adult ADHD assessment. Her emerging areas of interest include the ethical use of AI to maintain therapeutic momentum and accelerate growth between visits, while enriching clinical decision-making with dynamic data that supports more personalized, precise, and adaptive therapy. -
Alan G. Cheng, MD
Edward C. and Amy H. Sewall Professor in the School of Medicine, Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsActive Wnt signaling maintains somatic stem cells in many organ systems. Using Wnt target genes as markers, we have characterized distinct cell populations with stem cell behavior in the inner ear, an organ thought to be terminally differentiated. Ongoing work focuses on delineating the developing significance of these putative stem/progenitor cells and their behavior after damage.
-
Evaline Cheng, MD
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsCardio-oncology
Cardiotoxicity
Delivery of care
Health care systems -
Hannah Cheng
Social Science Research Professional 3, Psych/Public Mental Health & Population Sciences
BioHannah Cheng, MS is a Research Scientist at the Stanford Center for Dissemination and Implementation. Her overarching goal is to leverage implementation science to dismantle systemic barriers and improve access to behavioral health services. Her work focuses on identifying strategies to implement innovations in resource-limited settings and integrating economic evaluations in implementation research to maximize return on investment
-
Jordan C. Cheng, DMD, PhD
Postdoctoral Scholar, Stanford Cancer Institute
Current Research and Scholarly InterestsMy research direction involves the evalutation of single-stranded library prepartion methods versus conventional double-stranded methods of cell-free DNA for non-invasive cancer profiling applications. The exploration of these technologies allow for the inference of the genomic and epigenetic features of both local and distant cell types associated with a biofluid.
-
Paul Cheng MD PhD
Assistant Professor of Medicine (Cardiovascular Medicine)
BioDr. Cheng is a Cardiologist at Stanford University School of Medicine in the Department of Medicine and a member of the Cardiovascular Research Institute. Dr. Cheng received his BEng in Chemical Engineering and BSc in biology at MIT. He subsequently completed his MD/PhD at UCSF working in the Srivastava lab studying how extracellular morphogenic signals affect cardiac development and fate determination of cardiac progenitors. Dr. Cheng completed internal medicine residency and cardiology fellowship at Stanford, including a post-doctoral training in the Quertermous lab. His current clinical focus is in amyloidosis and cardio-oncology.
Dr. Cheng pioneered the application of single cell transcriptomic and epigenetic techniques to study human vascular diseases including atherosclerosis and aneurysm, and applied these techniques to investigate molecular mechanisms behind genetic risk factors for several human vascular diseases including atherosclerosis, and aortopathies such as Marfan's and Loey-Dietz syndrome. The Cheng lab takes a patient-to-bench-to-bedside approach to science. The lab focuses on elucidating new pathogenic mechanisms of human vascular diseases through combing human genetics and primary vascular disease tissues, with high-resolution transcriptomic and epigenetic profiling to generate novel hypothesis that are then tested in a variety of in vitro and in vivo models. The lab is focused on two broad questions: (1) understanding the biological underpinning of the differences in diseases propensities of different arterial segments in an individual (i.e. why do you have atherosclerosis and aneurysms in certain segments but not others), and (2) understanding the role of perivascular fibroblast in human vascular diseases.
Find out more about what the Cheng lab is up to, check out https://chenglab.stanford.edu -
Tiffany Cheng
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
BioI am a physician leader and anesthesiologist at Stanford Health Care, where I serve as Medical Director of Perioperative Services at SHC Palo Alto and hold a faculty appointment as Clinical Assistant Professor at Stanford University School of Medicine.
My work sits at the intersection of direct patient care and systems-level leadership. I have a track record of building high-performing clinical teams, designing governance structures from the ground up, and delivering measurable operational impact — including significant improvements in OR utilization, block efficiency, and access to care across Stanford's interventional platform.
I founded Stanford's Anesthesiology Mentorship Program (AMP), a faculty development initiative that received the Augustus A. White III Award, and co-founded ASPIRE, a multi-institutional speaker exchange network. I am a graduate of Stanford's Physician Leadership Certificate Program and will begin an Executive MBA at Santa Clara University in Fall 2026.
I believe that the strongest clinical institutions are built on trust, accountability, and a genuine investment in the people doing the work — and I bring that conviction to every leadership role I hold.
